EUVIMEDEUVIMED entdecken
Crossref

Downregulation of HDAC9 Alleviates Autophagy Dysfunction by Inducing Acetylation of ATG4B in Metabolic Dysfunction‐Associated Steatotic Liver Disease

Xiao-Han Ma iD, Guang-Peng Liu iD, Le Liu iD, Zi-Yue Dou iD, Xue He iD, Xi Chen iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202501627r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Xiao-Han Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Autophagy, Histone Deacetylases, Autophagy-Related Proteins, Cysteine Endopeptidases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), | University Natural Science Research Project of Anhui Province (), National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction–associated steatotic liver disease (MASLD) is a prevalent hepatic metabolic disorder with a rising global incidence. Epigenetic modifications—such as methylation, acetylation, phosphorylation, and ubiquitination—play critical roles in the initiation and progression of MASLD. This study utilized two datasets, GSE89632 and GSE202379. By intersecting 2602 differentially expressed genes (DEGs) with 720 epigenetic factor‐related genes (EF‐RGs), 91 candidate genes were identified. Protein–protein interaction (PPI) network analysis, machine learning, and single‐cell sequencing collectively identified HDAC9 as the hub gene. HDAC9 was found to be highly expressed in db/db mice and patients with MASLD and positively correlated with liver enzymes and serum lipids in patients with MASLD. Loss‐of‐function experiments confirmed its pathogenic role in MASLD in both in vitro and in vivo models. Silencing HDAC9 reduced the severity of fibrosis and inflammation, while also alleviating autophagy dysfunction in db/db mice and palmitic acid–treated human liver sinusoidal endothelial cells (hLSECs). Mechanistically, HDAC9 was shown to decrease H3K9 acetylation at the promoter region of ATG4B, a key autophagy regulator, thereby suppressing ATG4B transcription and impairing autophagy in MASLD. In conclusion, this study demonstrates that HDAC9 expression increases alongside clinical indicators of MASLD, and HDAC9 knockdown alleviates fibrosis and inflammation and restores autophagy by enhancing ATG4B acetylation. Therefore, HDAC9 may serve as a potential biomarker for the prevention and treatment of MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyHistone DeacetylasesAutophagy-Related ProteinsCysteine EndopeptidasesRepressor ProteinsFatty LiverAnimalsHumansMiceAcetylationDown-RegulationMaleMice, Inbred C57BLLiver

Stichwörter der Autor:innen

acetylationautophagyhistone deacetylase 9liver sinusoidal endothelial cellsmetabolic dysfunction‐associated steatotic liver disease

Substanzen

Histone DeacetylasesAutophagy-Related ProteinsCysteine EndopeptidasesHDAC9 protein, humanATG4B protein, humanRepressor ProteinsHdac9 protein, mouse

Autor:innen und Institutionen

  • Department of Gastroenterology, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Anhui Provincial Key Laboratory of Digestive Disease, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

ORCID-Profile: Xiao-Han Ma, Guang-Peng Liu, Le Liu, Zi-Yue Dou, Xue He, Xi Chen

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • | University Natural Science Research Project of Anhui Province ()
  • National Natural Science Foundation of China
  • University Natural Science Research Project of Anhui Province

Zitieren

APA

Ma, X. H., Liu, G. P., Liu, L., Dou, Z. Y., He, X., & Chen, X. (2025). Downregulation of HDAC9 Alleviates Autophagy Dysfunction by Inducing Acetylation of ATG4B in Metabolic Dysfunction‐Associated Steatotic Liver Disease. The FASEB Journal. https://doi.org/10.1096/fj.202501627r

Vancouver

Ma XH, Liu GP, Liu L, Dou ZY, He X, Chen X. Downregulation of HDAC9 Alleviates Autophagy Dysfunction by Inducing Acetylation of ATG4B in Metabolic Dysfunction‐Associated Steatotic Liver Disease. The FASEB Journal. 2025. doi:10.1096/fj.202501627r

BibTeX
@article{Ma2025,
  author = {Ma, Xiao-Han and Liu, Guang-Peng and Liu, Le and Dou, Zi-Yue and He, Xue and Chen, Xi},
  title = {Downregulation of HDAC9 Alleviates Autophagy Dysfunction by Inducing Acetylation of ATG4B in Metabolic Dysfunction‐Associated Steatotic Liver Disease},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202501627r}
}
Kostenlos starten →